Lauriane Nallet-Khosrofian (ETH Zurich) reports on the FENS Forum of Neuroscience Conference, including gender bias, alternative careers, as well as her highlights of the event.
In this NCTalks podcast, Lauren Pulling speaks to Irene Tracey to hear more about her talk on imaging perception and lessons from pain, analgesia and anesthesia.
At the FENS Forum of Neuroscience (7–11 July, Berlin, Germany), researchers have come together to present their work on novel treatments for multiple sclerosis.
Stem cells and brain organoids were the focus of a symposium during the FENS Forum…
Researchers may be able to diagnose and treat Alzheimer’s disease before it becomes symptomatic, through a dietary drug which could be more effective than current treatments.
Scientists have demonstrated how variations in a gene linked to anxiety and depression could affect a patient’s response to treatment.
Research has demonstrated that traumatic effects caused by a stressful experience can lead to epigenetic changes to gene activity; these changes can be passed on, and therefore result in behavioral changes in future generations.
Lausanne University Hospital (Switzerland) researchers reveal the promise of genome editing for the treatment of Huntington’s disease.
The link between emotional processing and our immune responses – as seen in the placebo effect – could lead to new avenues for treating psychiatric diseases, according to research.
Researchers reveal that post-traumatic stress disorder, anxiety and some types of inflammation may be alleviated by cannabis-like drugs.